Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Histone deacetylases 1 and 2 restrain CD4+ cytotoxic T lymphocyte differentiation
Teresa Preglej, Patricia Hamminger, Maik Luu, Tanja Bulat, Liisa Andersen, Lisa Göschl, Valentina Stolz, Ramona Rica, Lisa Sandner, Darina Waltenberger, Roland Tschismarov, Thomas Faux, Thorina Boenke, Asta Laiho, Laura L. Elo, Shinya Sakaguchi, Günter Steiner, Thomas Decker, Barbara Bohle, Alexander Visekruna, Christoph Bock, Birgit Strobl, Christian Seiser, Nicole Boucheron, Wilfried Ellmeier
Teresa Preglej, Patricia Hamminger, Maik Luu, Tanja Bulat, Liisa Andersen, Lisa Göschl, Valentina Stolz, Ramona Rica, Lisa Sandner, Darina Waltenberger, Roland Tschismarov, Thomas Faux, Thorina Boenke, Asta Laiho, Laura L. Elo, Shinya Sakaguchi, Günter Steiner, Thomas Decker, Barbara Bohle, Alexander Visekruna, Christoph Bock, Birgit Strobl, Christian Seiser, Nicole Boucheron, Wilfried Ellmeier
View: Text | PDF
Research Article Immunology

Histone deacetylases 1 and 2 restrain CD4+ cytotoxic T lymphocyte differentiation

  • Text
  • PDF
Abstract

Some effector CD4+ T cell subsets display cytotoxic activity, thus breaking the functional dichotomy of CD4+ helper and CD8+ cytotoxic T lymphocytes. However, molecular mechanisms regulating CD4+ cytotoxic T lymphocyte (CD4+ CTL) differentiation are poorly understood. Here we show that levels of histone deacetylases 1 and 2 (HDAC1-HDAC2) are key determinants of CD4+ CTL differentiation. Deletions of both Hdac1 and 1 Hdac2 alleles (HDAC1cKO-HDAC2HET) in CD4+ T cells induced a T helper cytotoxic program that was controlled by IFN-γ–JAK1/2–STAT1 signaling. In vitro, activated HDAC1cKO-HDAC2HET CD4+ T cells acquired cytolytic activity and displayed enrichment of gene signatures characteristic of effector CD8+ T cells and human CD4+ CTLs. In vivo, murine cytomegalovirus–infected HDAC1cKO-HDAC2HET mice displayed a stronger induction of CD4+ CTL features compared with infected WT mice. Finally, murine and human CD4+ T cells treated with short-chain fatty acids, which are commensal-produced metabolites acting as HDAC inhibitors, upregulated CTL genes. Our data demonstrate that HDAC1-HDAC2 restrain CD4+ CTL differentiation. Thus, HDAC1-HDAC2 might be targets for the therapeutic induction of CD4+ CTLs.

Authors

Teresa Preglej, Patricia Hamminger, Maik Luu, Tanja Bulat, Liisa Andersen, Lisa Göschl, Valentina Stolz, Ramona Rica, Lisa Sandner, Darina Waltenberger, Roland Tschismarov, Thomas Faux, Thorina Boenke, Asta Laiho, Laura L. Elo, Shinya Sakaguchi, Günter Steiner, Thomas Decker, Barbara Bohle, Alexander Visekruna, Christoph Bock, Birgit Strobl, Christian Seiser, Nicole Boucheron, Wilfried Ellmeier

×

Figure 5

Enforced expression of ThPOK partially blocks the upregulation of Th cytotoxic features in HDAC1cKO-HDAC2HET CD4+ T cells.

Options: View larger image (or click on image) Download as PowerPoint
Enforced expression of ThPOK partially blocks the upregulation of Th cyt...
(A) Experimental strategy: naive WT and HDAC1cKO-HDAC2HET CD4+ T cells were activated with anti-CD3/anti-CD28 in the presence of IL-2 (d-1); 24 hours later (d0) were transduced with “empty” control-EGFP (CTRL) and ThPOK-EGFP retroviral vectors, respectively; and were further cultured for 3 days. (B) Histograms at the left depict EGFP+ expression in transduced CD4+ T cells. The other histograms depict IFN-γ, granzyme B, T-bet, and EOMES expression in EGFP+ WT and HDAC1cKO-HDAC2HET CD4+ T cells transduced with either CTRL or ThPOK retroviral vectors. (C) Histograms depict RUNX3 and CRTAM expression in EGFP+ WT and HDAC1cKO-HDAC2HET CD4+ T cells transduced with CTRL or ThPOK vector. (D) Summary of experiments described in B and C. Diagrams depict ether the percentages of CD4+ T cells expressing the indicated cytokines/transcription factors; or WT (CTRL) MFI levels were set as 1, and relative MFI levels in WT (ThPOK) and HDAC1cKO-HDAC2HET (CTRL/ThPOK) CD4+ T cells are shown. Each symbol indicates 1 independent biological sample. Horizontal bars indicate the mean. *P < 0.05, **P < 0.01, and ***P < 0.001 (1-way ANOVA analysis followed by Tukey’s multiple-comparisons test). (B and C) Numbers indicate the percentage of cells in the respective regions or, as indicated, the MFI. The dotted vertical lines indicate the peak of the WT histogram (for MFI), while the vertical solid lines indicate the gating region for the percentage of cells. (B–D) Data are representative of at least 4 independent biological samples that were analyzed in at least 3 independent experiments.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts